Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Tonix Pharm Hld (TNXP)

Tonix Pharm Hld (TNXP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 272,720
  • Shares Outstanding, K 264,777
  • Annual Sales, $ 0 K
  • Annual Income, $ -28,620 K
  • 60-Month Beta 1.57
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.93
Trade TNXP with:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6011 +71.35%
on 12/23/20
1.1500 -10.43%
on 01/13/21
+0.4586 (+80.26%)
since 12/22/20
3-Month
0.5100 +101.96%
on 11/10/20
1.1500 -10.43%
on 01/13/21
+0.3564 (+52.91%)
since 10/22/20
52-Week
0.3900 +164.10%
on 02/25/20
2.4600 -58.13%
on 07/21/20
-0.2800 (-21.37%)
since 01/22/20

Most Recent Stories

More News
Tonix Pharmaceuticals Announces Publication of Patent Application for TNX-1500 (Monoclonal Antibody Anti-CD40-Ligand) in Development for Preventing and Treating Organ Transplant Rejection and Treating Autoimmune Conditions

GMP Production of TNX-1500 is Expected to be Available in the Third Quarter of 2021

TNXP : 1.0300 (+5.10%)
Tonix Pharmaceuticals Holdings Corp. Closes $40M Common Stock Offering Priced At-the-Market Under Nasdaq Rules

TONIX PHARMACEUTICALS HOLDINGS CORP. (NASDAQ: TNXP) ("Tonix" or the "Company"), a clinical-stage biopharmaceutical company, today announced the closing of its previously announced registered direct offering,...

TNXP : 1.0300 (+5.10%)
Sidoti Virtual Investor Conference

GRYCF : 0.3835 (-2.07%)
TNXP : 1.0300 (+5.10%)
CIR : 36.23 (-0.03%)
INS : 39.99 (+1.09%)
EML : 25.50 (+3.87%)
BHR : 4.80 (+2.13%)
SWM : 41.35 (+0.10%)
VNRX : 4.46 (+11.22%)
ORN : 5.85 (-0.85%)
III : 3.60 (+1.69%)
VSEC : 41.39 (+3.11%)
OTTR : 41.60 (+0.87%)
CULP : 15.82 (+2.59%)
FORR : 44.14 (+0.98%)
Tonix Pharmaceuticals Holdings Corp. Prices $40M Common Stock Offering Priced at-the-Market Under Nasdaq Rules

TONIX PHARMACEUTICALS HOLDINGS CORP. (NASDAQ: TNXP) ("Tonix" or the "Company"), a clinical-stage biopharmaceutical company, today announced it has entered into a securities purchase agreement with institutional...

TNXP : 1.0300 (+5.10%)
Further Research into Psilocybin Opens New Doors for Treatment

, /PRNewswire/ -- Among the popular fields of study for biotech companies in recent years are gene editing, tissue engineering and regeneration, nanobiotechnology and others. In addition, new segments...

MYCOF : 0.4200 (-2.33%)
MYCO.CN : 0.530 (-3.64%)
LLY : 206.14 (+1.87%)
RVVTF : 0.4570 (+6.28%)
HSTRF : 0.3149 (-3.08%)
TNXP : 1.0300 (+5.10%)
Tonix Pharmaceuticals to Participate in Upcoming January Conferences

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that Seth Lederman, M.D., President and Chief Executive Officer of...

TNXP : 1.0300 (+5.10%)
Tonix Pharmaceuticals and Massachusetts General Hospital (MGH) Enter into Research Collaboration on Tonix's Third Generation anti-CD40-Ligand Monoclonal Antibody, TNX-1500, for the Treatment and Prevention of Kidney Transplant Rejection

Expands Ongoing Research Collaboration Between Tonix and MGH Studying TNX-1500 in Heart Transplantation

TNXP : 1.0300 (+5.10%)
Tonix Pharmaceuticals Plans Commercial Scale Vaccine Manufacturing Facility

Hamilton, MT Facility Is Planned to Manufacture Vaccines at Commercial Scale, Including Vaccines Under Development for COVID-19

TNXP : 1.0300 (+5.10%)
Tonix Pharmaceuticals Acquires Exclusive License to University of Geneva Technology for Oxytocin-Based Treatments for Treating Insulin Resistance, Diabetes and Obesity, Expanding Proprietary Uses for TNX-1900 (Intranasal Potentiated Oxytocin)

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced an agreement whereby Tonix has acquired the exclusive license to the...

TNXP : 1.0300 (+5.10%)
Psychedelics Industry Gearing Up For an Even Bigger 2021

, /PRNewswire/ -- Investments continued flowing into the psychedelic medicine sector this year and will likely continue in 2021 as mental illness cases rise across the globe. The World Health Organization...

JNJ : 163.55 (+1.13%)
TNXP : 1.0300 (+5.10%)
NUMI.VN : 1.600 (+3.90%)
LKYSF : 1.2500 (+1.63%)
CMPS : 48.32 (+7.55%)
MYCO.CN : 0.530 (-3.64%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Tonix Pharmaceuticals Holding Corp. is a specialty pharmaceutical company focused on developing new pharmaceutical products for CNS conditions. The Company develops therapies for disorders that include fibromyalgia syndrome and post-traumatic stress disorder. Its lead product candidates include TNX-102,...

See More

Key Turning Points

3rd Resistance Point 1.1833
2nd Resistance Point 1.1267
1st Resistance Point 1.0783
Last Price 1.0300
1st Support Level 0.9733
2nd Support Level 0.9167
3rd Support Level 0.8683

See More

52-Week High 2.4600
Fibonacci 61.8% 1.6693
Fibonacci 50% 1.4250
Fibonacci 38.2% 1.1807
Last Price 1.0300
52-Week Low 0.3900

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar